Scilex Holding (SCLXW) Enterprise Value (2020 - 2026)

Scilex Holding (SCLXW) recorded quarterly Enterprise Value of -$149.9 million in Q1 2026, down 891.17% quarter-over-quarter from -$15.1 million in Q4 2025, and down 2484.9% on a YoY basis from $6.3 million in Q1 2025.

Scilex Holding (SCLXW) Enterprise Value (2020 - 2026) Analysis & Trends

Scilex Holding's Enterprise Value history runs 7 years deep, the most recent figure standing at -$149.9 million for Q1 2026.

  • In Q1 2026, Enterprise Value fell 2484.9% year-over-year to -$149.9 million; the TTM figure through Mar 2026 stood at -$149.9 million (down 2484.9% YoY), while the FY2025 annual figure was -$15.1 million, down 362.29% from the prior year.
  • Enterprise Value was -$149.9 million for Q1 2026 at Scilex Holding, down from -$15.1 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$69922.0 in Q3 2022 to a low of -$149.9 million in Q1 2026.
  • Historically, Enterprise Value has averaged -$30.6 million across 5 years, with a median of -$4.1 million in 2025.
  • Biggest YoY gain for Enterprise Value was 98.48% in 2022; the steepest drop was 55034.43% in 2022.
  • A 5-year view of Enterprise Value shows it stood at -$2.2 million in 2022, then tumbled by 79.53% to -$3.9 million in 2023, then gained by 16.55% to -$3.3 million in 2024, then plunged by 362.29% to -$15.1 million in 2025, then sank by 891.17% to -$149.9 million in 2026.
  • The last three Enterprise Value figures came in at -$149.9 million (Q1 2026), -$15.1 million (Q4 2025), and -$3.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -4.96 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -5.28 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn -22.05 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -9.35 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -5.65 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -12.04 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn -7.73 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -12.77 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -10.45 Bn
10 Scilex Holding - - 4.15 Mn -149.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -149.92 Mn
Dec 31, 2025 -15.13 Mn
Sep 30, 2025 -3.68 Mn
Jun 30, 2025 -4.10 Mn
Mar 31, 2025 -5.80 Mn
Dec 31, 2024 -3.27 Mn
Sep 30, 2024 -77,000.00
Jun 30, 2024 -6.89 Mn
Mar 31, 2024 -1.82 Mn
Dec 31, 2023 -3.92 Mn
Sep 30, 2023 -2.00 Mn
Jun 30, 2023 -34.12 Mn
Mar 31, 2023 -5.10 Mn
Dec 31, 2022 -2.18 Mn
Sep 30, 2022 -69,922.00
Jun 30, 2022 -142.04 Mn
Mar 31, 2022 -140.58 Mn
Dec 31, 2021 -143.75 Mn
Sep 30, 2021 -115,642.00
Jun 30, 2021 -257,621.00